Teknoloji

TR EN AR RU KK
Total Market Cap 7,066.6B
P/E (Weighted)Price to Earnings ratio. 38.78 Medyan: 19.17
P/B (Weighted)Price to Book ratio. 5.00 Medyan: 2.42
P/E (Arithmetic)Simple average P/E. 27.88
Avg Lothien ScoreFinancial health score (0-100). 49
Avg DamodaranDamodaran scoring model. 39
Avg PotentialExpected upside potential %. +13.8%
Avg Dalio ScoreDalio debt cycle score. 74
Distributions
Lothien Distribution
0–25
12
25–40
19
40–55
14
55–70
19
70–100
13
Damodaran Distribution
0–25
19
25–40
24
40–55
14
55–70
14
70–100
6
Upside Potential
-100% – -20%
32
-20% – +0%
3
+0% – +20%
7
+20% – +50%
12
+50%+
18

Data date 2026-10-16 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-10-16
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
9911
 8.81 11.2B 1.53 0.59 — 31.6% 12.5% 90 87 26.43 +148.0% 98 0.04
3888
 25.60 34.8B 10.72 1.10 1.41 49.8% 11.9% 89 84 68.22 +124.9% 96 0.01
9898
 50.15 12.3B 4.93 0.39 2.98 7.5% 9.7% 89 69 140.94 +135.8% 75 0.47
1478
 4.70 5.6B 3.20 0.74 3.10 8.9% 8.0% 84 70 14.10 +150.0% 78 0.65
3969
 3.01 31.9B 7.36 0.54 2.77 10.8% 9.6% 84 66 7.53 +112.6% 85 0.20
9899
 84.75 17.4B 5.39 1.15 5.62 11.6% 11.9% 81 65 170.87 +76.2% 100 0.00
0856
 8.19 11.7B 8.65 1.15 7.25 10.7% 8.7% 79 63 18.04 +90.2% 71 0.91
2357
 3.04 24.2B 11.72 0.59 2.37 17.3% 8.3% 78 76 8.26 +128.9% 75 0.74
0696
 9.12 26.7B 9.70 0.95 4.99 12.9% 11.2% 78 60 17.75 +70.9% 96 0.09
1698
 32.80 106.9B 10.22 1.16 7.49 11.3% 9.3% 76 64 63.36 +69.9% 91 0.22
2400
 40.44 19.3B 10.68 4.30 7.11 655.6% 11.8% 76 72 58.06 +32.7% 100 0.03
2018
 35.48 41.1B 13.91 1.43 5.87 9.1% 9.8% 76 58 66.15 +64.9% 84 0.44
0285
 22.38 50.3B 11.54 1.24 4.30 9.0% 10.3% 74 60 54.06 +106.2% 84 0.26
1686
 5.03 11.9B 10.38 1.84 12.17 6.1% 7.1% 70 54 9.29 +61.0% 45 2.50
2038
 12.27 9.6B 23.14 0.80 1.42 -7.7% 13.0% 69 34 28.14 +82.7% 81 0.08
2391
 13.24 8.1B 15.06 1.01 6.01 15.8% 12.8% 68 61 21.90 +49.0% 95 0.01
0751
 3.11 5.8B 13.88 0.28 5.37 3.4% 3.7% 68 54 7.17 +98.1% 67 1.04
1989
 81.90 38.7B 19.85 4.16 18.43 28.6% 11.7% 68 71 106.11 +22.2% 94 0.10
0136
 1.51 25.0B 11.83 0.89 5.06 2.4% 10.8% 67 37 2.25 +35.1% 88 0.11
0992
 25.98 333.2B 3.37 6.21 15.87 30.1% 10.9% 66 69 29.11 +9.0% 73 0.71
9698
 24.52 38.2B 8.72 1.01 11.53 1.7% 6.0% 66 44 39.76 +36.7% 54 1.46
2476
 150.00 147.4B 24.05 3.32 21.30 11.7% 10.2% 64 56 218.60 +34.3% 89 0.27
0763
 19.29 92.3B 19.36 1.02 12.98 4.9% 7.7% 64 54 34.27 +55.9% 60 0.90
9611
 18.36 9.6B 18.98 1.12 16.64 2.2% 7.9% 63 53 31.41 +53.3% 68 0.79
2507
 38.78 14.2B 15.06 1.95 7.07 23.7% 12.9% 61 48 39.87 +2.0% 94 0.03
3355
 33.20 13.5B 17.53 2.46 12.45 16.3% 12.5% 61 46 29.46 -8.1% 96 0.10
9626
 110.70 46.3B 25.70 2.48 25.58 6.2% 9.9% 60 50 125.53 +10.1% 66 0.60
2643
 11.11 6.5B — — 32.61 131.7% 7.0% 60 84 18.47 +37.1% 23 —
0522
 136.10 57.1B 27.65 3.30 13.25 3.2% 11.3% 58 44 145.64 +5.0% 88 0.23
6682
 21.78 11.3B — 1.28 — -2.2% 12.7% 57 34 38.69 +37.3% 86 0.03
0553
 2.69 2.5B 21.12 0.68 9.67 -1.8% 14.3% 56 32 3.29 +14.5% 84 0.00
1357
 3.53 16.0B 23.31 2.40 11.58 17.4% 11.0% 55 56 3.79 +5.7% 92 0.26
0020
 1.14 47.5B — 1.51 — -10.0% 10.7% 54 26 1.68 +22.8% 77 0.22
2865
 9.81 3.1B — 0.69 — -4.9% 6.4% 52 35 29.43 +86.0% 42 1.75
0241
 2.96 47.7B 21.06 2.28 15.20 12.5% 11.9% 52 37 2.09 -21.3% 95 0.00
1860
 10.83 17.4B 100.00 5.08 16.08 20.6% 12.0% 50 55 12.64 +12.6% 86 0.05
0800
 10.87 10.1B — 1.35 — -65.7% 12.3% 50 20 17.18 +27.9% 84 0.10
3986
 335.00 235.1B 20.26 5.38 21.29 28.6% 10.9% 49 53 200.17 -30.2% 97 0.00
2518
 39.06 18.0B 13.57 0.70 38.58 1.5% 11.9% 48 29 29.70 -17.3% 94 0.00
2498
 14.60 6.9B — 1.54 — -18.0% 12.3% 47 23 21.08 +21.3% 85 0.09
6088
 3.94 28.0B 22.89 1.34 7.41 4.2% 8.8% 47 29 3.64 -5.6% 75 0.70
4333
 750.00 2,959.5B 26.08 7.50 19.96 18.3% 10.0% 45 44 404.92 -34.5% 75 0.59
2026
 39.30 17.1B — 1.38 — -17.6% 11.8% 44 19 62.30 +28.1% 82 0.01
3296
 53.40 113.3B 23.70 3.01 16.97 8.2% 8.7% 42 39 35.67 -24.9% 69 0.91
0501
 62.95 79.4B 24.71 2.07 15.79 10.9% 9.6% 40 35 37.07 -29.6% 88 0.36
3277
 55.35 24.1B 69.67 13.14 54.80 44.3% 11.9% 40 44 15.57 -53.9% 97 0.00
6809
 202.00 246.9B 60.71 9.78 58.27 35.5% 10.9% 37 44 53.69 -55.1% 98 0.01
2676
 136.00 22.1B — 2.44 — 0.9% 11.1% 36 28 54.64 -33.5% 83 0.21
6166
 81.60 30.0B 57.90 2.74 59.29 9.2% 11.4% 35 30 32.22 -45.4% 83 0.17
6869
 122.60 100.8B 100.00 6.21 52.93 6.6% 10.0% 33 25 37.98 -51.8% 72 0.75
2442
 39.60 16.2B — 74.47 487.15 18.1% 11.9% 33 28 9.90 -51.7% 92 0.00
6810
 55.85 16.7B 63.81 6.79 41.92 12.3% 11.0% 33 29 15.05 -54.8% 76 0.70
2577
 31.70 28.5B — 5.75 — -10.0% 11.1% 32 22 12.23 -29.5% 62 0.55
2706
 27.26 11.0B — — — — — 32 42 — — 32 —
3317
 68.10 18.7B — 6.76 — -0.9% 11.9% 31 31 22.76 -31.9% 88 0.03
2658
 45.20 17.8B — 5.57 215.49 -0.3% 10.7% 31 26 12.78 -36.6% 54 0.85
1384
 15.37 5.4B — 4.00 — -41.2% 12.7% 30 19 7.03 -26.1% 81 0.12
1385
 21.96 18.1B 66.23 2.51 43.58 11.5% 11.2% 29 28 7.79 -48.4% 83 0.25
9678
 64.15 4.6B — 5.59 — -9.8% 11.9% 29 26 23.12 -27.5% 59 0.53
3881
 17.60 7.4B — 3.79 — -66.1% 11.8% 28 20 9.26 -22.7% 69 0.41
3896
 4.45 20.0B — 1.92 2,088.19 -0.5% 9.8% 27 28 2.02 -27.9% 40 0.77
0068
 4.75 8.2B — — — — — 26 26 1.19 -32.2% 34 —
2726
 80.00 9.5B 100.00 2.69 130.82 0.7% 12.0% 26 25 37.64 -39.7% 64 0.29
1347
 76.55 1,043.9B 100.00 20.12 341.61 — — 26 0 19.14 -51.7% 71 0.49
2889
 58.90 8.8B — 3.49 — -22.2% 10.3% 25 21 29.93 -21.2% 56 1.05
6082
 24.98 60.9B — 5.21 — -9.4% 11.8% 25 16 6.25 -36.0% 82 0.03
9660
 3.83 56.1B — 3.78 — -47.3% 9.9% 25 18 1.90 -21.7% 53 1.04
2718
 28.52 3.9B — 1.40 — 1.5% 12.2% 24 28 12.25 -31.9% 70 0.11
0600
 19.75 11.6B — — — — — 23 40 — — 20 —
2533
 7.88 5.4B — 3.99 — -208.8% 11.4% 23 20 3.32 -24.9% 55 0.67
9903
 79.80 61.6B — 22.28 — -43.7% 11.7% 23 5 19.95 -36.0% 80 0.43
6636
 64.50 7.2B — 28.60 — -11.2% 12.8% 21 17 16.12 -32.2% 57 0.34
6651
 40.82 16.3B — 19.19 — -45.9% 11.7% 20 8 10.20 -36.0% 78 0.41
2526
 218.80 19.4B — 21.42 — -24.2% 11.9% 20 0 54.70 -36.0% 83 0.07
0100
 180.80 55.2B — — — — — 13 0 — — 27 —
1879
 219.60 20.2B — — — — — 13 0 — — 32 —
2513
 513.50 226.1B — — — — — 13 0 — — 34 —

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.